Jayne Gershkowitz - Net Worth and Insider Trading
Jayne Gershkowitz Net Worth
The estimated net worth of Jayne Gershkowitz is at least $64,274 dollars as of 2024-09-21. Jayne Gershkowitz is the SVP, Chief Patient Advocate of Amicus Therapeutics Inc and owns about 5,693 shares of Amicus Therapeutics Inc (FOLD) stock worth over $64,274. Details can be seen in Jayne Gershkowitz's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jayne Gershkowitz has not made any transactions after 2015-07-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jayne Gershkowitz
Jayne Gershkowitz Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jayne Gershkowitz owns 1 companies in total, including Amicus Therapeutics Inc (FOLD) .
Click here to see the complete history of Jayne Gershkowitz’s form 4 insider trades.
Insider Ownership Summary of Jayne Gershkowitz
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2015-07-01 | VP & Patient Advocacy |
Jayne Gershkowitz Latest Holdings Summary
Jayne Gershkowitz currently owns a total of 1 stock. Jayne Gershkowitz owns 5,693 shares of Amicus Therapeutics Inc (FOLD) as of July 1, 2015, with a value of $64,274.
Latest Holdings of Jayne Gershkowitz
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FOLD | Amicus Therapeutics Inc | 2015-07-01 | 5,693 | 11.29 | 64,274 |
Holding Weightings of Jayne Gershkowitz
Jayne Gershkowitz Form 4 Trading Tracker
According to the SEC Form 4 filings, Jayne Gershkowitz has made a total of 0 transactions in Amicus Therapeutics Inc (FOLD) over the past 5 years. The most-recent trade in Amicus Therapeutics Inc is the sale of 10,649 shares on July 1, 2015, which brought Jayne Gershkowitz around $148,767.
Insider Trading History of Jayne Gershkowitz
- 1
Jayne Gershkowitz Trading Performance
Jayne Gershkowitz Ownership Network
Jayne Gershkowitz Owned Company Details
What does Amicus Therapeutics Inc do?
Who are the key executives at Amicus Therapeutics Inc?
Jayne Gershkowitz is the VP & Patient Advocacy of Amicus Therapeutics Inc. Other key executives at Amicus Therapeutics Inc include director & President and CEO Bradley L Campbell , director & Executive Chairman John F Crowley , and Chief People Officer David Michael Clark .
Amicus Therapeutics Inc (FOLD) Insider Trades Summary
Over the past 18 months, Jayne Gershkowitz made no insider transaction in Amicus Therapeutics Inc (FOLD). Other recent insider transactions involving Amicus Therapeutics Inc (FOLD) include a net sale of 351,367 shares made by John F Crowley , a net sale of 233,261 shares made by Bradley L Campbell , and a net sale of 95,000 shares made by Ellen Rosenberg .
In summary, during the past 3 months, insiders sold 22,500 shares of Amicus Therapeutics Inc (FOLD) in total and bought 0 shares, with a net sale of 22,500 shares. During the past 18 months, 822,412 shares of Amicus Therapeutics Inc (FOLD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 822,412 shares.
Amicus Therapeutics Inc (FOLD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amicus Therapeutics Inc Insider Transactions
Jayne Gershkowitz Mailing Address
Above is the net worth, insider trading, and ownership report for Jayne Gershkowitz. You might contact Jayne Gershkowitz via mailing address: 1 Cedar Brook Drive, Cranbury Nj 08512.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
